Clinical Trial Update: Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing paroxetine for comorbid social anxiety disorder and alcohol use disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Social Anxiety Disorder

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Social Anxiety Disorder, Social Phobia | Phase 4 | Status: COMPLETED | Results posted: 2018-09-27